Article · 30 Dec 2024
Market analysisPublished 2021
Clinical Research Conference for Global Market and Biomarkers in Dubai, UAE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In 2017, North America signified the major share in the biomarker market. The Asia Pacific verified the highest growth from 2017 to 2022 for the biomarker advances to market. Factors such as the growing rate of malignancy, the development of the geriatric population and the support of private and public links for biomarker research are driving the development of this regional section. By influencing advance, the biomarker breakthrough market is categorized by immunoassays, PCR, mass spectrometry, NGS, chromatography, cytogenetic and other different advances. The immunoassay percentage accounted for most of it in 2017. This section is additionally categorized into ELISA, western blot and protein microarrays. In 2017, the ELISA fragment exemplified the major share in the immunoassay market.
Keywords
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Biomarkers Journal.
Article · 30 Dec 2024
Genomic Biomarkers: Bridging the Gap between Genetics and Precision Medicine
Article · 30 Dec 2024
Cryogenic Markers: Advancing Low Temperature Science and Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomarkers Journal
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Salama Ali”